Clinical Trial Update: Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cryoablation with tislelizumab and chemotherapy as neoadjuvant and adjuvant therapy for resectable stage II-IIIB non-small cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: NSCLC (Non-small Cell Lung Cancer) | Phase 2 | Status: RECRUITING